newsfilter.io

Cecilia Arradaza

Showing 1–3 of 3 transcripts.

  1. Milken Institute1h 3m

    From Marketer to Influencer to Global Brand Shaper

    Beth Brady, Matt Durella, Hannah Groove, Mark Wilson, Nancy Kanwisher, Hannah Hartmann, Cecilia Giovannini, Mark Siegelmann, Martha Minowski, Margaret Brennan, Nicole Sinclair, Caroline O, David Kwong, Shirley Moody, Tana, Angela Duckworth, Nina Savari, Mark Goulston, Mark McCurry, Mark Zuckerberg, Cecilia Arradaza

    Executives from Principal Financial Group, Twitter, State Street, and BlackBerry convened at a Milken Institute panel to redefine marketing as a strategic revenue driver driven by data and cross-functional integration. The discussion highlighted a sector-wide pivot where leaders leverage hyper-personalization, advanced attribution modeling, and security imperatives to transform complex industries into consumer-centric ecosystems. Participants emphasized that future success relies on cultivating trust through simplified storytelling and rapidly iterating strategies to convert marketing from a cost center into a critical business engine.

  2. Milken Institute1h 4m

    Big Data for Better Cures: Where to Invest?

    Cecilia Arradaza, Marty Cohn, Joel Dudley, Magali Haas, Risa Sack, Andy von Eschenbach, Harlan Weissman, Garrett, Mary Dwight

    Leading healthcare experts including Marty Cohn, Joel Dudley, and Andy von Eschenbach converged to identify that while big data offers potential to reduce waste and personalize care, its adoption is currently stifled by incentive misalignment, fragmented data silos, and a regulatory framework built on pre-market rather than post-market surveillance. The panel consensus highlighted that shifting from fee-for-service to value-based care and establishing a "model of the normal" human are critical prerequisites for unlocking predictive analytics in chronic disease and neurology. To advance these goals, the speakers urged the creation of broad consent models, common data standards for cross-organizational sharing, and new reimbursement structures that specifically reward data utility over collection.

  3. Milken Institute1h 22m

    Stopping Alzheimer's: Personal, Economic and Policy Imperatives

    Neil de Crescenzo, Robert Hormats, Sue Siegel, George Vradenburg, Anne Whitaker, Cecilia Arradaza, Bob Hormats, Peggy Wallace, Michael Miller

    With Alzheimer's disease imposing a global economic burden equivalent to an $18th-largest national economy and a 97% research failure rate, experts call for a strategic shift from viewing the condition as merely a health issue to addressing it as a sovereign economic crisis. Key figures and organizations, including the NIH, GE, and the BRAIN Initiative, are urging a tripling of funding to $2 billion annually alongside the development of validated biomarkers to overcome current diagnostic and regulatory barriers. To mitigate this fiscal threat and extend productive lifespans, stakeholders propose cross-sector collaboration to create new financial instruments and public awareness campaigns that mobilize caregivers and policymakers toward systemic reform.